Cas no 143979-23-1 (Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI))
Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) Chemical and Physical Properties
Names and Identifiers
-
- Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI)
- 2-Methyl-2-Propanyl (3-Amino-2-Methyl-3-Oxopropyl)Carbamate
- EN300-7127826
- DTXSID601152705
- PFAQHEWBPXANNT-UHFFFAOYSA-N
- Carbamic acid, (3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester
- tert-Butyl (3-amino-2-methyl-3-oxopropyl)carbamate
- SCHEMBL5478424
- 143979-23-1
- Carbamic acid, (3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI)
- TERT-BUTYL N-(2-CARBAMOYL-2-METHYLETHYL)CARBAMATE
- Methyl-3-(t-butoxycarbonylamino)propionic amide
- tert-butyl N-(3-amino-2-methyl-3-oxopropyl)carbamate
-
- Inchi: 1S/C9H18N2O3/c1-6(7(10)12)5-11-8(13)14-9(2,3)4/h6H,5H2,1-4H3,(H2,10,12)(H,11,13)
- InChI Key: PFAQHEWBPXANNT-UHFFFAOYSA-N
- SMILES: O(C(NCC(C(N)=O)C)=O)C(C)(C)C
Computed Properties
- Exact Mass: 202.13184
- Monoisotopic Mass: 202.13174244g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 5
- Complexity: 221
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.3
- Topological Polar Surface Area: 81.4?2
Experimental Properties
- PSA: 81.42
Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-7127826-0.05g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 0.05g |
$162.0 | 2023-06-02 | |
| Enamine | EN300-7127826-0.1g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 0.1g |
$241.0 | 2023-06-02 | |
| Enamine | EN300-7127826-0.25g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 0.25g |
$347.0 | 2023-06-02 | |
| Enamine | EN300-7127826-0.5g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 0.5g |
$546.0 | 2023-06-02 | |
| Enamine | EN300-7127826-1.0g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 1g |
$699.0 | 2023-06-02 | |
| Enamine | EN300-7127826-2.5g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 2.5g |
$1370.0 | 2023-06-02 | |
| Enamine | EN300-7127826-5.0g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 5g |
$2028.0 | 2023-06-02 | |
| Enamine | EN300-7127826-10.0g |
tert-butyl N-(2-carbamoyl-2-methylethyl)carbamate |
143979-23-1 | 95% | 10g |
$3007.0 | 2023-06-02 | |
| Aaron | AR00AM0D-50mg |
Carbamic acid, (3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) |
143979-23-1 | 95% | 50mg |
$248.00 | 2025-02-14 | |
| Aaron | AR00AM0D-100mg |
Carbamic acid, (3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) |
143979-23-1 | 95% | 100mg |
$357.00 | 2025-02-14 |
Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) Related Literature
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
Additional information on Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI)
Carbamic Acid, (3-Amino-2-Methyl-3-Oxopropyl), 1,1-Dimethylethyl Ester (9CI)
The compound with CAS No. 143979-23-1, known as Carbamic acid, (3-amino-2-methyl-3-oxopropyl), 1,1-dimethylethyl ester (9CI), is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The carbamic acid moiety serves as a central functional group, while the ester linkage provides versatility in chemical reactivity and biological activity.
Recent studies have highlighted the importance of carbamic acid derivatives in modulating enzyme activity and cellular signaling pathways. The (3-amino-2-methyl-3-oxopropyl) group attached to the carbamic acid introduces a branched structure that enhances its ability to interact with specific biological targets. This structural feature has been linked to improved bioavailability and reduced toxicity in preclinical models.
The 1,1-dimethylethyl ester group further modifies the physicochemical properties of the molecule, making it more amenable for use in pharmaceutical formulations. Researchers have explored its potential as a prodrug, where the ester group can be cleaved under physiological conditions to release the active moiety. This approach has shown promise in enhancing drug delivery efficiency and minimizing side effects.
Emerging research has also focused on the synthesis of this compound using environmentally friendly methods. Green chemistry techniques, such as catalytic asymmetric synthesis and biocatalysis, have been employed to optimize the production process. These advancements not only improve yield but also reduce the environmental footprint associated with traditional synthetic routes.
In terms of applications, Carbamic acid, (3-amino-2-methyl-3-oxopropyl), 1,1-dimethylethyl ester (9CI) has been investigated for its role in inhibiting key enzymes involved in inflammatory processes. Preclinical studies suggest that it may serve as a potential therapeutic agent for chronic inflammatory diseases such as arthritis and neuroinflammation.
Furthermore, computational modeling studies have provided insights into the molecular interactions of this compound with target proteins. These studies utilize advanced algorithms to predict binding affinities and optimize molecular design for enhanced efficacy.
In conclusion, Carbamic acid, (3-amino-2-methyl-3-oxopropyl), 1,1-dimethylethyl ester (9CI) represents a promising compound with diverse applications in drug discovery and development. Its unique structure and functional groups make it a valuable tool for researchers exploring novel therapeutic strategies.
143979-23-1 (Carbamic acid,(3-amino-2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI)) Related Products
- 65983-35-9(tert-Butyl (3-amino-3-oxopropyl)carbamate)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)